1. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity
   Simone Aparecida De Bessa Garcia et al, 2017, International Journal of Molecular Medicine CrossRef
2. Expression of PAWR predicts prognosis of ovarian cancer
   Jiahong Tan et al, 2020, Cancer Cell International CrossRef
3. PAR-4: a possible new target for age-related disease
   Wu Qinan et al, 2014, Expert Opinion on Therapeutic Targets CrossRef
4. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
   Stephanie N. Dorman et al, 2016, Molecular Oncology CrossRef
5. Chemoresistance and targeted therapies in ovarian and endometrial cancers
   Kevin Brasseur et al, 2017, Oncotarget CrossRef
6. miR-17-3P regulates the proliferation and survival of colon cancer cells by targeting Par4
   Debao Lu et al, 2017, Molecular Medicine Reports CrossRef
7. Regulation of Caspase-Mediated Apoptosis by the Tumor Suppressor Par-4
   James Sledziona et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
8. Suppression of macrophages- Induced inflammation via targeting RAS and PAR-4 signaling in breast cancer cell lines
   Nadia A. Thabet et al, 2019, Toxicology and Applied Pharmacology CrossRef
9. Involvement of Par-4 in Breast Cancer
   Simone Aparecida de Bessa-Garcia et al, 2021, Tumor Suppressor Par-4 CrossRef
10. Drug resistance in gynecologic cancers: Findings and underlying mechanisms
    Luna Acharya et al, 2021, Overcoming Drug Resistance in Gynecologic Cancers CrossRef
11. miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4)
    Fen Liu et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
12. Arylquin 1 (Potent Par-4 Secretagogue) Inhibits Tumor Progression and Induces Apoptosis in Colon Cancer Cells
    Yi-Ting Chen et al, 2022, International Journal of Molecular Sciences CrossRef
13. The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells
    Yinxing Liu et al, 2014, Acta Neuropathologica CrossRef
14. Integrative proteomic and microRNA analysis of the priming phase during rat liver regeneration
    Xiaofang Geng et al, 2016, Gene CrossRef
15. Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target
    Seon Min Woo et al, 2015, Journal of Life Science CrossRef
16. Prostate apoptosis response-4 and tumor suppression: it’s not just about apoptosis anymore
    Anees Rahman Cheratta et al, 2021, Cell Death & Disease CrossRef
17. Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells
    Kevin Brasseur et al, 2016, Oncotarget CrossRef
18. Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?
    Renata Virgínia Cavalcanti Santos et al, 2019, Current Drug Targets CrossRef
19. SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid
    Mahitab G. Haggagy et al, 2024, Scientific Reports CrossRef